Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 312

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Cholesterol-lowering effects of oat β-glucan: Nutrition Reviews©, Vol. ••(••): ••-••

Othman, Rgia A, Moghadasian, Mohammed H, Jones, Peter JH · 2011 · Nutrition Reviews

Abstract

Elevated total and low-density lipoprotein (LDL) cholesterol levels are considered major risk factors for cardiovascular disease. Oat β-glucan, a soluble dietary fiber that is found in the endosperm cell walls of oats, has generated considerable interest due to its cholesterol-lowering properties. The United States Food and Drug Administration (FDA) approved a health claim for β-glucan soluble fiber from oats for reducing plasma cholesterol levels and risk of heart disease in 1997. Similarly, in 2004 the United Kingdom Joint Health Claims Initiative (JHCI) allowed a cholesterol-lowering health claim for oat β-glucan. The present review aims to investigate if results from more recent studies are consistent with the original conclusions reached by the FDA and JHCI. Results of this analysis show that studies conducted during the past 13 years support the suggestion that intake of oat β-glucan at daily doses of at least 3 g may reduce plasma total and low-density lipoprotein (LDL) cholesterol levels by 5-10% in normocholesterolemic or hypercholesterolemic subjects. Studies described herein have shown that, on average, oat consumption is associated with 5% and 7% reductions in total and LDL cholesterol levels, respectively. Significant scientific agreement continues to support a relationship between oat β-glucan and blood cholesterol levels, with newer data being consistent with earlier conclusions made by the FDA and JHCI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1753-4887.2011.00401.x

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Research works printed but not linked: 6

  1. U.S. Food and Drug Administration, 1997, FDA final rule for federal labeling: health claims; oats and coronary heart disease, Fed Regist., 62, 3584
  2. Wang, 2008, Sulfated beta-glucan derived from oat bran with potent anti-HIV activity, J Agric Food Chem., 56, 2624, 10.1021/jf072888h · doi:10.1021/jf072888h
  3. United States Department of Health and Human Services, Food and Drug Administration, 1996, Health claims: oats and coronary heart disease - proposed rule, Fed Regist., 61, 296
  4. Johnston, 1998, Cholesterol-lowering benefits of a whole grain oat ready to eat cereal, Nutr Clin Care., 1, 6
  5. Anderson, 1981, Plant-fibre metabolites alter hepatic glucose and lipid metabolism, Diabetes., 30, 133A
  6. Immerstrand, 2010, Effects of oat bran, processed to different molecular weights of beta-glucan, on plasma lipids and caecal formation of SCFA in mice, Br J Nutr., 104, 364, 10.1017/S0007114510000553 · doi:10.1017/s0007114510000553

Cited by

See all 312

Metadata

Authors
Othman, R. A., Moghadasian, M. H., & Jones, P. J.
Venue
Nutrition Reviews
Published
2011-06
Volume
69
Issue
6
Pages
299-309
ISSN
0029-6643 (ISSN-L)
OpenAlex
W2131693569
Cited by
312
References
65
FWCI
11.78
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cholesterol-lowering effects of oat β-glucan: Nutrition Reviews©, Vol. ••(••): ••-••. https://app.cochat.ai/papers/10.1111/j.1753-4887.2011.00401.x
The paper
Othman, R. A., Moghadasian, M. H., & Jones, P. J. (2011). Cholesterol-lowering effects of oat β-glucan: Nutrition Reviews©, Vol. ••(••): ••-••. Nutrition Reviews. https://doi.org/10.1111/j.1753-4887.2011.00401.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.